$2.2B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | AUPH Aurinia Pharmaceuticals Inc | 13.0M | +6.7% | $221M | 10.1% |
| 2 | SYRE Spyre Therapeutics Inc | 1.9M | +0.0% | $168M | 7.6% |
| 3 | MIRM Mirum Pharmaceuticals Inc | 1.2M | +0.0% | $145M | 6.6% |
| 4 | KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl | 2.3M | +0.0% | $145M | 6.6% |
| 5 | CELC Celcuity Inc | 1.3M | +25.2% | $138M | 6.2% |
| 6 | CORT Corcept Therapeutics Inc | 1.5M | +0.0% | $130M | 5.9% |
| 7 | PTCT Ptc Therapeutics Inc | 1.5M | +0.0% | $122M | 5.6% |
| 8 | LKFT Lakefront Biotherapeutics | 3.8M | +0.0% | $114M | 5.2% |
| 9 | CAPR Capricor Therapeutics Inc | 4.1M | +20.6% | $99M | 4.5% |
| 10 | TARS Tarsus Pharmaceuticals Inc | 1.6M | +31.9% | $99M | 4.5% |
| 11 | SPY State Str Spdr S&P 500 Etf T | 123,000 | −26.8% | $92M | 4.2% |
| 12 | ANAB Anaptysbio Inc | 1.3M | +0.0% | $90M | 4.1% |
| 13 | IMCR Immunocore Hldgs Plc | 2.6M | +0.0% | $84M | 3.8% |
| 14 | CMPS Compass Pathways Plc | 5.0M | +24.9% | $71M | 3.2% |
| 15 | ANIP Ani Pharmaceuticals Inc | 707,500 | +0.0% | $59M | 2.7% |
| 16 | BNTX Biontech Se | 470,000 | +0.0% | $44M | 2.0% |
| 17 | CMPX Compass Therapeutics Inc | 18.0M | +7.1% | $39M | 1.8% |
| 18 | PGEN Precigen Inc | 6.4M | +0.0% | $37M | 1.7% |
| 19 | VRDN Viridian Therapeutics Inc | 1.8M | +0.0% | $33M | 1.5% |
| 20 | NVCT Nuvectis Pharma Inc | 1.6M | — | $29M | 1.3% |
| 21 | DNTH Dianthus Therapeutics Inc | 264,692 | +0.0% | $26M | 1.2% |
| 22 | FULC Fulcrum Therapeutics Inc | 6.5M | — | $24M | 1.1% |
| 23 | AVIR Atea Pharmaceuticals Inc | 4.8M | +0.0% | $22M | 1.0% |
| 24 | CBIO Crescent Biopharma Inc. | 1.2M | +0.0% | $21M | 0.9% |
| 25 | NNDM Nano Dimension Ltd | 14.3M | — | $21M | 0.9% |
| 26 | VKTX Viking Therapeutics Inc | 500,000 | +0.0% | $20M | 0.9% |
| 27 | NUVB Nuvation Bio Inc | 3.3M | +4.8% | $19M | 0.9% |
| 28 | IDYA Ideaya Biosciences Inc | 450,000 | +0.0% | $17M | 0.8% |
| 29 | DERM Journey Med Corp | 1.6M | +0.0% | $11M | 0.5% |
| 30 | INSM Insmed Inc | 100,000 | −61.5% | $11M | 0.5% |
| 31 | STOK Stoke Therapeutics Inc | 300,000 | −40.0% | $10M | 0.4% |
| 32 | PLRX Pliant Therapeutics Inc | 6.1M | −0.0% | $7M | 0.3% |
| 33 | BOLD Boundless Bio Inc | 2.6M | — | $6M | 0.3% |
| 34 | PMVP Pmv Pharmaceuticals Inc | 4.2M | +0.0% | $6M | 0.3% |
| 35 | MRNA Moderna Inc | 50,000 | −50.0% | $4M | 0.2% |
| 36 | WVE Wave Life Sciences Ltd | 600,000 | +0.0% | $3M | 0.2% |
| 37 | HRTX Heron Therapeutics Inc | 6.2M | +0.0% | $3M | 0.1% |
| 38 | LENZ Lenz Therapeutics Inc | 451,114 | +0.0% | $3M | 0.1% |
| 39 | ALT Altimmune Inc | 666,022 | +0.0% | $2M | 0.1% |
| 40 | RCKT Rocket Pharmaceuticals Inc | 100,000 | +0.0% | $342,000 | 0.0% |